Our recent studies indicate that head and neck cancer including OSCC is characterized by the expression of Id1 and NF-κB in the majority of clinical patients by microarrays (7,8) and cancer cells, rich in these two proteins are by nature aggressive and have poor clinical outcomes (9–12). Here, NFKB1 is linked to head and neck cancer.